If VHL gets good phase II results from the VIR-201 trial it's gonna fly! Therapeutic vaccines just received an absolutely HUGE vote of confidence from the biggest player in the industry... the FDA.
I hope Virax management are following the story, and leverage via an investor roadshow or the like.
Victory smells close!
VHL Price at posting:
8.8¢ Sentiment: Buy Disclosure: Held